Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer

DSpace/Manakin Repository

Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer

Citable link to this page

 

 
Title: Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer
Author: Gallenne, Tristan; Ross, Kenneth N.; Visser, Nils L.; Salony; Desmet, Christophe J.; Wittner, Ben S.; Wessels, Lodewyk F.A.; Ramaswamy, Sridhar; Peeper, Daniel S.

Note: Order does not necessarily reflect citation order of authors.

Citation: Gallenne, Tristan, Kenneth N. Ross, Nils L. Visser, SalonyChristophe J. Desmet, Ben S. Wittner, Lodewyk F.A. Wessels, Sridhar Ramaswamy, and Daniel S. Peeper. 2017. “Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer.” Oncotarget 8 (13): 20572-20587. doi:10.18632/oncotarget.16244. http://dx.doi.org/10.18632/oncotarget.16244.
Full Text & Related Files:
Abstract: Prognostic classifiers conceivably comprise biomarker genes that functionally contribute to the oncogenic and metastatic properties of cancer, but this has not been investigated systematically. The transcription factor Fra-1 not only has an essential role in breast cancer, but also drives the expression of a highly prognostic gene set. Here, we systematically perturbed the function of 31 individual Fra-1-dependent poor-prognosis genes and examined their impact on breast cancer growth in vivo. We find that stable shRNA depletion of each of nine individual signature genes strongly inhibits breast cancer growth and aggressiveness. Several factors within this nine-gene set regulate each others expression, suggesting that together they form a network. The nine-gene set is regulated by estrogen, ERBB2 and EGF signaling, all established breast cancer factors. We also uncover three transcription factors, MYC, E2F1 and TP53, which act alongside Fra-1 at the core of this network. ChIP-Seq analysis reveals that a substantial number of genes are bound, and regulated, by all four transcription factors. The nine-gene set retains significant prognostic power and includes several potential therapeutic targets, including the bifunctional enzyme PAICS, which catalyzes purine biosynthesis. Depletion of PAICS largely cancelled breast cancer expansion, exemplifying a prognostic gene with breast cancer activity. Our data uncover a core genetic and prognostic network driving human breast cancer. We propose that pharmacological inhibition of components within this network, such as PAICS, may be used in conjunction with the Fra-1 prognostic classifier towards personalized management of poor prognosis breast cancer.
Published Version: doi:10.18632/oncotarget.16244
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400527/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:33029906
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters